A phase‐1, open‐label, single‐dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairment

por Csonka, Denes, Hazell, Katharine, Waldron, Edward, Lorenzo, Sebastien, Duval, Vincent, Trandafir, Lucia, Kobalava, Zhanna D.
Publicado 2016

Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma

por Mu, Song, Kuroda, Yoshiaki, Shibayama, Hirohiko, Hino, Masayuki, Tajima, Takeshi, Corrado, Claudia, Lin, Rong, Waldron, Edward, Binlich, Florence, Suzuki, Kenshi
Publicado 2015

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

por Pulsipher, Michael A., Han, Xia, Maude, Shannon L., Laetsch, Theodore W., Qayed, Muna, Rives, Susana, Boyer, Michael W., Hiramatsu, Hidefumi, Yanik, Gregory A., Driscoll, Tim, Myers, G. Doug, Bader, Peter, Baruchel, Andre, Buechner, Jochen, Stefanski, Heather E., Kalfoglou, Creton, Nguyen, Kevin, Waldron, Edward R., Thudium Mueller, Karen, Maier, Harald J., Kari, Gabor, Grupp, Stephan A.
Publicado 2022

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma

por Thudium Mueller, Karen, Grupp, Stephan A., Maude, Shannon L., Levine, John E., Pulsipher, Michael A., Boyer, Michael W., August, Keith J., Myers, G. Doug, Tam, Constantine S., Jaeger, Ulrich, Foley, Stephen Ronan, Borchmann, Peter, Schuster, Stephen J., Waller, Edmund K., Awasthi, Rakesh, Potthoff, Bernd, Warren, Andy, Waldron, Edward R., McBlane, Fraser, Chassot-Agostinho, Andrea, Laetsch, Theodore W.
Publicado 2021